Global Liver Institute
Beyond the Biopsy
GLOBAL LIVER INSTITUTE
Beyond the Biopsy Overview
Going Beyond the Biopsy
Resources
Dedicated to accelerating the acceptance and adoption of non-invasive diagnostics.
Global Liver Institute’s Beyond the Biopsy (BTB) initiative seeks to accelerate the acceptance and adoption of noninvasive diagnostics to address the rapidly growing prevalence of liver diseases worldwide. While liver
biopsies have their role, noninvasive options offer safer, more readily accessible ways to assess liver health. As noninvasive technologies and pharmacologics advance, GLI is expanding BTB to develop strategies for use in primary care, community clinics, emergency departments, and rural and remote healthcare settings.
Testimonials
Patient Voices
Jenny
Jenny
Jenny
Jenny
Jenny
Jenny
Jenny
Jenny
Jenny
Jenny
“The biopsy was very frightening. It’s degrading using bedpans, and horrendous lying motionless for hours afterwards. I have since had more biopsies, each one equally painful and traumatic – meaning time off from work for my husband or daughter”
Kimberly
Kimberly
“I only found out my diagnosis, NASH, from my discharge papers. I found out what NASH was by looking it up on Google. I definitely would have benefited from point-of-care patient counseling.”
Terri
“I am grateful to be part of the Global Liver Institute’s Liver Action Network and Fatty Liver Disease Council, where stories like mine can drive efforts to improve public policies for patients with liver disease and liver cancer.”